Effect of excipient on drug release and permeation from silicone-based barrier devices

Journal of Controlled Release

Volumn 43, Issue 2-3, 1997, Pages 283-290

  Lee, Chi Hyun ^a   Bhatt, Padmanabh P ^b   Chien, Yie W ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b DOW CORNING CORPORATION   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Diaphragm; Excipients; Fertility control; In vitro release and permeation study; Intravaginal device; Nonoxynol 9

Indexed keywords

EXCIPIENT; NONOXINOL 9; SILASTIC; SILICONE; SPERMICIDAL AGENT;

AFFECT; ANIMAL TISSUE; ARTICLE; DIAPHRAGM; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; LAMB; NONHUMAN; PRIORITY JOURNAL; SPERM; VAGINA MUCOSA; VAGINAL DELIVERY;

EID: 0031060183     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01498-8     Document Type: Article

References (19)

1. K. Tojo, J.A. Masi, J.A. and Y.W. Chien, Hydrodynamic characteristics of an in vitro drug permeation cell. Ind. Eng. Chem. Fundam. 24 (1985) 368.
2. Y.W. Chien, Intravaginal Controlled-Release Drug Administration in Novel Drug Delivery Systems. Marcel Dekker, New York, Ch. 3, 1992.
3. C.H. Lee, R. Bagdon, P.P. Bhatt and Y.W. Chien, Development of silicon-based barrier devices for controlled delivery of spermicidal agent. J. Cont. Rel. (1995) submitted.
4. D. Abrutyn, B.E. McKenzie and N. Nadaskay, Teratology study of intravaginally administered N-9 containing contraceptive cream in rats. Fertil. Steril. 37 (1982) 113.
5. F.N. Judson, J.M. Ehret, G.F. Bodin, M.J. Levin and C.A. Rietmeiyer, In vitro evaluations of condoms with and without Nonoxynol-9 as physical and chemical barriers against chlamydia trachomatis, Herpes simplex virus type 2 and human immunodeficiency virus. Sex. Trans. Dis. 16 (1989) 51-56.
6. F. Barbone, H. Austin, W.C. Lauv and W.J. Alexander, A follow-up study of methods of contraception, sexual activity and rates of trichomneasis condidiasis and bacterial vaginosis. Am. J. Obstet. Gynecol. 163 (1990) 510-514.
7. D. Viza, A. Aranda-Anzaldo, C. Zompetti and J.M. Vich, Dimethyl-sulfoxide inhibits HIV production in vitro. Intervirology 32 (1991) 59-64.
8. B.A. Wallace, Gramicidin channels and pores. Annu. Rev. Biophys. Chem. 19 (1990) 127.
9. A.S. Bourinbaiar, K. Krasinski and W. Borkowsky, Anti-HIV effect of gramicidin in vitro: potential for spermicide use. Life Sci. 54 (1994) PL 5-9.
10. C.J. Elias and L. Heise, Challenges for the development of female-controlled vaginal microbicides. AIDS 8 (1994) 1-9.
11. E. Chantler, H. Fisher, S. Solanki and M. Elstein, Quantification of the in vitro activity of some compounds with spermicidal activity. Contraception 46 (1992) 527.
12. A.L. Gadd and P.B. Curtis-Prior, Comparative effects of (+)-propranolol and N-9 on human sperm motility in vitro. J. Pharm. Pharmacol. 42 (1990) 593-594.
13. J.M. Kaminski, D. Smith, D.S. Reid, W. Kennedy, R.S. Jeyendran and L.J.D. Zaneveld, Effect of aryl 4-guanidinobenzoates on the acrosin activity of human spermatozoa. Biol. Reprod. 36 (1987) 1170-1176.
14. E.V. Sander and S.D. Cramer, A practical method for testing the spermicidal action of chemical contraceptives. Hum. Fertil. 6 (1941) 134.
15. D. Vantman, M. Zinaman, G. Koukoulis, R. Sherins and L. Dennison, Computer-assisted semen analysis: evaluation of method and assessment of the influence of sperm concentration on linear velocity determination. Fertil. Steril. 49 (1988) 510.
16. W.M. Saltzman and L.B. Tena, Spermicide permeation through biocompatible polymers. Contraception 43 (1991) 497.
17. M.B. Kabadi and Y.W. Chien, Intravaginal controlled administration of flurogestone acetate III: Development of rate-control vaginal devices. Drug Dev. Ind. Pharm. 11 (1985a) 1271-1312.
18. M.B. Kabadi and Y.W. Chien, Intravaginal controlled administration of flurogestone acetate IV: in vitro and in vivo correlation for intravaginal drug delivery from rate-control vaginal pessary. Drug Dev. Ind. Pharm. 11 (1985b) 1313-1361.
19. C.H. Lee and Y.W. Chien, In vitro permeation study of a mucoadhesive drug-delivery system for controlled delivery of nonoxynol-9. Pharm. Dev. Tech. 1(2) (1996) 135-145.